The abstract is read at the publisher; the summary is JClub's.
Fecal microbiota transplantation is the most effective available intervention for pediatric recurrent Clostridioides difficile infection, with multicenter cohorts showing cure rates exceeding 80%.
- Why it matters: Recurrent CDI affects up to 30% of children after antibiotics, and comorbidities can raise recurrence to as high as 65%, creating major treatment and safety needs.
- What they did: This review synthesizes evidence on pediatric FMT efficacy, microbiome changes, and safety, drawing on large multicenter cohort data and highlighting regulatory and trial gaps.
- The result: Cure rates exceed 80% and efficacy appears comparable in high-risk subgroups such as inflammatory bowel disease and immunocompromising conditions, but randomized trials and long-term pediatric safety data are limited.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.